Fovea Pharmaceuticals SA (Fovea), a biopharmaceutical company created in May
2005 by a team of experienced scientists and managers, announced today the closing
of a EUR20.5 million ($25 million) equity financing round. The international
syndicate was led by Sofinnova Partners (France) and includes Abingworth Management
(UK), The Wellcome Trust (UK), GIMV (Belgium) and Credit Agricole Private Equity (France).